Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

antibiotics

antibiotics is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 6
News articles 0
Drug details — antibiotics
Class
—
Route
—
Patents
20
Programs
6
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

antibiotics is an FDA-listed pharmaceutical active ingredient.

Key facts

INN antibiotics

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. RIPH_2019_01 Phase 3 · Tour Hekla · Adult with an staphylococcal prosthetic joint infection trea
  2. Reducing Antibiotics treatment duration Phase 3 · United Therapeutics Europe · Ventilator Associated Pneumonia
  3. Standard of Care PO (oral) antibiotics Phase 3 · United Therapeutics Europe · Infections
  4. probiotics, antibiotics or antidepressants Phase 3 · First People's Hospital · Irritable Bowel Syndrome
  5. Lenalidomide [Leavdo®] Phase 2 · Hospital Authority · Antibiotics-unresponsive MALT Lymphoma
  6. 222778 Phase 1 · GSK Glaxo Smith · Urinary Tract Infections

Related patents

Browse patents

  1. US 12369604

    Methods of inhibition with microbial strains and antibiotics

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12329747

    Use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bacterial infections within citrus and other plant species

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11446279

    Aromatic 2-nitrosulfonyl fluoride antibiotics and methods of use thereof

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11298561

    Method of treating multi-drug resistance biofilm using targeted laser and antibiotics

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10953040

    Methods of treating bacterial infections with penam β-lactam antibiotics and branched poly(ethylenimine)

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10610601

    Polymeric antibiotics

    Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10434114

    Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10125167

    Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics

    Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10105379

    Pharmaceutical compositions comprising three antibiotics

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9889204

    Polymeric antibiotics

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8933193

    Lantibiotics and uses thereof

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8557978

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8314217

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8084417

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8044195

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7960505

    Lantibiotics and uses thereof

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7728127

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7713931

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7655621

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7649080

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is antibiotics?

antibiotics is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.